Literature DB >> 789407

Immune potential in human uraemia. 1. Relationship of glomerular filtration rate to depression of immune potential.

P R Byron, N P Mallick, G Taylor.   

Abstract

Aspects of immune potential in uraemic subjects, categorized by glomerular filtration rate, were intercompared and compared with results obtained from a group of normal volunteers. Evidence is presented to show that depression of both cellular and humoral immune potential occurs with progressive reduction of glomerular filtration rate. Lymphocyte transformation testing to the non-specific mitogen PHA revealed a significant elevation of blastogenic response in uraemia after 96 hours of incubation.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 789407      PMCID： PMC476175          DOI： 10.1136/jcp.29.9.765

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  13 in total

1.  Tetanus antitoxin titration by haemagglutination.

Authors:  A J FULTHORPE
Journal:  J Hyg (Lond)       Date:  1957-09

2.  Prolonged survival of skin homografts in uremic patients.

Authors:  G J DAMMIN; N P COUCH; J E MURRAY
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

3.  Production of antbody in patients with uremia.

Authors:  I L STOLOFF; R STOUT; R M MYERSON; W P HAVENS
Journal:  N Engl J Med       Date:  1958-08-14       Impact factor: 91.245

4.  The effect of severe battle injury and of post-traumatic renal failure on resistance to infection.

Authors:  H H BALCH
Journal:  Ann Surg       Date:  1955-08       Impact factor: 12.969

5.  Accelerated nucleic-acid synthesis in uraemic lymphocytes.

Authors:  H Sakai; J C Daniels; J D Lindley; A R Remmers; H E Sarles; S E Ritzmann
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

6.  Immune responses in uremia.

Authors:  J M Boulton-Jones; R Vick; J S Cameron; P J Black
Journal:  Clin Nephrol       Date:  1973 Nov-Dec       Impact factor: 0.975

7.  In vitro reactivity of human lymphocytes in chronic uraemia: analysis and interpretation.

Authors:  J C Daniels; H Sakai; A R Remmers; H E Sarles; J C Fish; E K Cobb; W C Levin; S E Ritzmann
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

8.  The immunologic capability of uremic patients.

Authors:  J P Merrill
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

9.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

10.  Response of human blood lymphocytes to tuberculin PPD in tissue culture.

Authors:  A S Coulson; D G Chalmers
Journal:  Immunology       Date:  1967-04       Impact factor: 7.397
View more
  6 in total

1.  Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.

Authors:  J Raskova; A B Morrison; S M Shea; K Raska
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

Review 2.  Mechanisms in secondary hypogammaglobulinaemia.

Authors:  P G Riches; J R Hobbs
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

3.  The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.

Authors:  S R Holdsworth; M G Fitzgerald; C S Hosking; R C Atkins
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

4.  Effect of uremia on lymphocyte transformation and chemiluminescence by spleen cells of normal and Cryptococcus neoformans-infected mice.

Authors:  R A Fromtling; A M Fromtling; F Staib; S Müller
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

5.  Immunomodulating properties of the uremic pentapeptide H-Asp-Leu-Trp-Glu-Lys-OH in vitro.

Authors:  D Niese; K Gilsdorf; E Hiester; P Dressen; S Michels; H J Dengler
Journal:  Klin Wochenschr       Date:  1986-07-15

6.  Studies on IL-2 production and T-cell colony forming unit in patients with chronic renal failure.

Authors:  S K Ha; H S Cho; H Y Lee; H S Kim; K H Choi; D S Han; B K Lee; J D Kim
Journal:  Korean J Intern Med       Date:  1993-07       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.